“A lot of patients, I think, are not going to benefit from new technologies. We’ve literally put all of our new product development on hold … so we can afford to pay the stupid tax.”
– Lev Melinyshyn, President of Uresil, LLC, a manufacturer of specialized catheters in Skokie, Illinois, on the effect of Obamacare on medical device companies.
Advertisement
Advertisement